S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 InnovivaArQuleAnaptysBioAthenexOdonate Therapeutics
SymbolNASDAQ:INVANASDAQ:ARQLNASDAQ:ANABNASDAQ:ATNXNASDAQ:ODT
Price Information
Current Price$10.93$9.53$36.72$9.60$28.95
52 Week RangeN/ABuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyBuy
Consensus Price TargetN/A$12.86$102.86$23.83N/A
% Upside from Price TargetN/A34.91% upside180.11% upside148.26% upsideN/A
Trade Information
Market Cap$1.10 billion$1.10 billion$993.28 million$741.89 million$931.90 million
Beta1.422.241.5-0.211.77
Average Volume665,5052,252,721437,697757,246104,810
Sales & Book Value
Annual Revenue$261 million$25.76 million$5 million$89.10 millionN/A
Price / Sales4.2444.49198.668.33N/A
Cashflow$4.16 per shareN/AN/AN/AN/A
Price / Cash2.63N/AN/AN/AN/A
Book Value$1.57 per share$0.72 per share$18.18 per share$1.92 per share$4.62 per share
Price / Book6.9613.242.025.00N/A
Profitability
Net Income$395.05 million$-15,480,000.00$-61,660,000.00$-117,440,000.00$-88,960,000.00
EPS$3.53($0.16)($2.50)($1.44)($3.64)
Trailing P/E Ratio3.10N/AN/AN/AN/A
Forward P/E Ratio10.21N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins146.60%-349.34%N/A-161.17%N/A
Return on Equity (ROE)307.49%-33.45%-16.61%-85.39%-78.04%
Return on Assets (ROA)74.31%-26.42%-15.75%-45.59%-68.36%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.57%0.07%N/A0.34%N/A
Current Ratio42.50%12.54%14.07%2.62%9.61%
Quick Ratio42.50%12.54%14.07%2.33%9.61%
Ownership Information
Institutional Ownership Percentage75.65%85.25%N/A48.30%96.52%
Insider Ownership Percentage0.18%13.80%14.00%18.80%59.30%
Miscellaneous
Employees63678575117
Shares Outstanding101.26 million120.26 million27.05 million77.28 million32.19 million
Next Earnings Date10/30/2019 (Estimated)10/30/2019 (Confirmed)11/14/2019 (Estimated)11/13/2019 (Estimated)10/22/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable
 InnovivaArQuleAnaptysBioAthenexOdonate Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel